SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending amidst its upcoming earnings, as community discussion highlights the growing revenue from its prediction markets. However, recent user frustrations with platform stability during major events and an ongoing debate about its ties to cryptocurrency performance are also key talking points.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is trending amidst an upcoming earnings report, with community sentiment sharply divided on whether its AI-driven lending model will lead to a significant rally or a further drop. Discussions are also heating up around the potential impact of a proposed credit card interest rate cap, which could either boost Upstart's personal loan demand or be seen as a broader headwind for fintech.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending sharply lower following FDA restrictions on compounded GLP-1 ingredients and a patent infringement lawsuit from Novo Nordisk, which has forced the company to halt sales of its oral semaglutide pill. The community is actively debating if the stock is a falling knife headed for single digits or setting up for a massive short squeeze given its high short interest.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is trending after exceeding earnings expectations and securing a major warrant deal with Amazon for future purchases, with the community actively debating its crucial position in AI infrastructure connectivity amid its characteristic volatility.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan Green in 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is experiencing renewed investor interest following a strong Q4 earnings report, which highlighted record bookings, significant EPS growth, and a new $1 billion share repurchase program. However, community sentiment remains divided as the market continues to weigh these positive financial developments against persistent concerns regarding robotaxi competition and ongoing acquisition speculation.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending as investors anticipate its upcoming earnings, with community discussion highlighting recent analyst upgrades and excitement around its pivotal role in AI infrastructure, driven by the viral 'Moltbot' AI assistant leveraging its edge computing and Workers platform.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending ahead of its earnings release, where a significant EV restructuring charge and outlook for 2026, especially regarding its hybrid strategy, are key discussion points. The community is split between optimism for Ford's pivot and analyst upgrades, and concerns over recent recalls and the broader challenges facing the auto sector.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending as its solid Q4 performance and increased dividend are contrasted by a conservative 2026 earnings outlook, sparking community discussion on whether this presents a buying opportunity amid perceived near-term weakness.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X (CCCX) is trending as its merger target, Infleqtion, gained significant attention for securing a NASA space mission and a DOE contract, with the community highly anticipating the upcoming merger vote on February 12th and NYSE debut as INFQ on February 17th. Investors are actively discussing Infleqtion's perceived undervaluation compared to quantum peers, emphasizing its superior neutral-atom technology and established government contracts in defense, space, and energy as key drivers for substantial upside post-merger.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending after its Q4 earnings report showed profitability but cautious 2026 guidance and a strategic exit from a business line, triggering a substantial sell-off. The community is vigorously debating whether the market's reaction is an unjustified manipulation of an undervalued stock or a reflection of management's prudent risk management within a challenging fintech landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Candriam S.C.A. Raises Holdings in Syndax Pharmaceuticals, Inc. $SNDX

Candriam S.C.A. lifted its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 37.1% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm...

Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen upgraded shares of Syndax Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday...

Insider Selling: Syndax Pharmaceuticals (NASDAQ:SNDX) CFO Sells 2,082 Shares of Stock

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) CFO Keith Goldan sold 2,082 shares of Syndax Pharmaceuticals stock in a transaction dated Friday, February 6th. The stock was sold at an...

Michael Metzger Sells 7,412 Shares of Syndax Pharmaceuticals (NASDAQ:SNDX) Stock

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) CEO Michael Metzger sold 7,412 shares of the company's stock in a transaction that occurred on Friday, February 6th. The shares were sold...

Keybank National Association OH Makes New $2.31 Million Investment in Syndax Pharmaceuticals, Inc. $SNDX

Keybank National Association OH acquired a new stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities...

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Brokerages

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the twelve ratings firms that are presently covering the company, Marketbeat...

Y Intercept Hong Kong Ltd Cuts Stock Position in Syndax Pharmaceuticals, Inc. $SNDX

Y Intercept Hong Kong Ltd trimmed its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 63.6% in the 3rd quarter, according to the company in its most recent 13F...

Mizuho Forecasts Strong Price Appreciation for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock

Mizuho boosted their target price on Syndax Pharmaceuticals from $410.00 to $600.00 and gave the stock an "outperform" rating in a research note on Tuesday...

Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Up 9.5% - What's Next?

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Up 9.5% - Time to Buy...

Sector Gamma AS Acquires New Shares in Syndax Pharmaceuticals, Inc. $SNDX

Sector Gamma AS acquired a new position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing...

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $SHOP earnings on Wednesday?

Current Price	$21.32
Prev Close	$21.19
Open	$21.09
Dividend Yield	0.00%
50-Day Moving Average	$20.63
Beta	1.16
Avg. Volume	1.33M
PE Ratio	-5.86

52-Week High	$22.73
52-Week Low	$8.58
Market Capitalization	$1.84B
EPS (Annual)	-$3.72
Price to Book	15.95
Revenue Per Employee	$87,703.70

SNDX
Syndax Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SNDX News

SNDXSyndax Pharmaceuticals Inc